Nimartem
Nimartem is an Artemisinin Combination Therapy (ACT) that has Artemether and Lumefantrine as its active constituents.
- Treatment of uncomplicated Falciparum malaria.
- Locally manufactured.
- High clearance rate of malaria parasite.
- It is readily available.
- Reduces the chance of relapse.
Directions
Nimartem Qs:
1 tablet twice daily for 3 days
Nimartem*24:
Children: Dose depends on body weight.
Adult: 4 tablets twice daily for 3 days.
